Open Access
Subscription Access
Evaluation of chemopreventive potential of xanthone from Swertia chirata against DMBA/croton oil-induced chemical carcinogenesis in Swiss mice
The present study was designed to determine the chemopreventive efficiency of 1,5,8-trihydroxy-3-methoxy xanthone, abbreviated as TMX, isolated and purified from the aerial part of the plant Swertia chirata against 9,10-dimethylbenz[a]-anthracene (DMBA)/croton oil-induced skin cancer, and probe into the molecular mechanism. All the mice in the carcinogen control group developed severe dysplastic lesions after the 14th week of application of the carcinogen, which progressed to carcinoma in situ around the 20th week; this was validated histologically. However, after TMX treatment, only around 50% of mice developed papilloma which histologically was found to be restrictive to moderate to severe hyperplastic change in the 14th and 20th week. The chemopreventive potential was determined by calculating the attributable risk (AR), which was –11.3 for the 14th week and increased up to –17.5 for the 20th week. To ascertain the effect of TMX treatment on inflammation, the effect of TMX on inflammatory cytokines was studied by ELISA. It revealed a significant reduction in inflammation upon TMX treatment for the 20th week. As TMX could hold its chemopreventive potential up to the 20th week, the molecular mechanism of restriction was studied for the 20th week of treatment. Skin forms a rich source of stem cells which orchestrate the progression of carcinogenesis and become cancer stem cells (CSCs). β-Catenin and KRAS are known central modulators of CSCs, that play a crucial role in the progression of skin carcinogenesis. We observed that TMX treatment inhibited KRAS and nuclear translocation of β-catenin causing its cytoplasmic degradation by P-53 and P-21-mediated pathway, thereby exerting its chemopreventive potential.
Keywords
Attributable risk, carcinogenesis, chemopreventive efficiency, mice, Swertia chirata, xanthone.
User
Font Size
Information
- Hennings, H. et al., Critical aspects of initiation, promotion, and progression in multistage epidermal carcinogenesis. Proc. Soc. Exp. Biol. Med., 1993, 202, 1–8.
- Slaga, T. J., Budunova, I. V., Gimenez-Conti, I. B. and Aldaz, C. M., The mouse skin carcinogenesis model. J. Invest. Dermatol. Symp. Proc., 1996, 1, 151–156.
- Behrens, J. et al., Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science, 1998, 280, 596–599. 4. Huang, H. and He, X., Wnt/β-catenin signaling: new (and old) players and new insights. Curr. Opin. Cell Biol., 2008, 20, 119– 125.
- Mosimann, C., Hausmann, G. and Basler, K., Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nature Rev. Mol. Cell Biol., 2009, 10, 276–286.
- Lee, S.-K., Hwang, J.-H. and Choi, K.-Y., Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis. Adv. Biol. Regul., 2018, 68, 46–54.
- Shin, W. et al., Identification of Ras-degrading small molecules that inhibit the transformation of colorectal cancer cells independent of β-catenin signaling. Exp. Mol. Med., 2018, 50, 1–10.
- Lin, J. C. et al., β-Catenin overexpression causes an increase in inflammatory cytokines and NF-κB activation in cardiomyocytes. Cell. Mol. Biol., 2016, 63, 17–22.
- Caulin, C. et al., An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations. J. Clin. Invest, 2007, 117, 1893–1901.
- Barua, A., Choudhury, P., Mandal, S., Panda, C. K. and Saha, P., Therapeutic potential of xanthones from Swertia chirata in breast cancer cells. Indian J. Med. Res., 2020, 152, 285–295.
- Barua, A., Choudhury, P., Mandal, S., Panda, C. K. and Saha, P., Anti-metastatic potential of a novel xanthone sourced by Swertia chirata against in vivo and in vitro breast adenocarcinoma frameworks. Asian Pac. J. Cancer Prev., 2020, 21, 2865–2875.
- Barua, A., Panda, C. and Saha, P., Chemotherapeutic potential of novel xathone sourced from Swertia chirata against skin carcinogenesis. Asian J. Pharm. Clin. Res., 2020, 13, 84–88.
- Barua, A., Choudhury, P., Maity, J. K., Mandal, S. B., Mandal, S. and Saha, P., Chemotherapeutic potential of novel non-toxic nucleoside analogues on EAC ascetic tumour cells. Free Radic. Res., 2019, 53, 57–67.
- Pal, D., Banerjee, S., Mukherjee, S., Roy, A., Panda, C. K. and Das, S., Eugenol restricts DMBA croton oil induced skin carcinogenesis in mice: downregulation of c-Myc and H-ras, and activation of p53 dependent apoptotic pathway. J. Dermatol. Sci., 2010, 59, 31–39.
- Habig, W. H., Pabst, M. J. and Jakoby, W. B., Glutathione Stransferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 1974, 249, 7130–7139.
- Johansson, L. H. and Borg, L. A., A spectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem., 1988, 174, 331–336.
- Paglia, D. E. and Valentine, W. N., Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 1967, 70, 158–169.
- Yamamoto, T. et al., Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. J. Pharmacol. Exp. Ther., 2004, 308, 317–323.
- Ohkawa, H., Ohishi, N. and Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 1979, 95, 351–358.
- Heidari-Soreshjani, S., Asadi-Samani, M., Yang, Q. and SaeediBoroujeni, A., Phytotherapy of nephrotoxicity-induced by cancer drugs: an updated review. J. Nephropathol., 2017, 6, 254–263.
- Sporn, M. B., Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res., 1976, 36, 2699–2702.
- Wu, C. F., Double-staining in toto with hematoxylin and eosin. Science, 1940, 92, 515–516.
- Prince, A. M. and Ginsberg, H. S., Immunohistochemical studies on the interaction between Ehrlich ascites tumor cells and Newcastle disease virus. J. Exp. Med., 1957, 105, 177–188.
- Perrone, F. et al., Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma. Clin. Cancer Res., 2006, 12, 6643–6651.
- Burnette, W. N., ‘Western blotting’: electrophoretic transfer of proteins from sodium dodecyl sulfate–polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem., 1981, 112, 195– 203.
- Schneeberger, C., Speiser, P., Kury, F. and Zeillinger, R., Quantitative detection of reverse transcriptase-PCR products by means of a novel and sensitive DNA stain. PCR Methods Appl., 1995, 4, 234–238.
- Baghirova, S., Hughes, B. G., Hendzel, M. J. and Schulz, R., Sequential fractionation and isolation of subcellular proteins from tissue or cultured cells. MethodsX, 2015, 2, 440–445.
- Hata, A. N., Engelman, J. A. and Faber, A. C., The BCL-2 family: key mediators of the apoptotic response to targeted anti-cancer therapeutics. Cancer Discov., 2015, 5, 475–487.
- Yu, Z., Pestell, T. G., Lisanti, M. P. and Pestell, R. G., Cancer stem cells. Int. J. Biochem. Cell Biol., 2012, 44, 2144–2151.
- Cheng, Y. et al., Physiological β-catenin signaling controls selfrenewal networks and generation of stem-like cells from nasopharyngeal carcinoma. BMC Cell Biol., 2013, 14, 44.
- Moon, B.-S., Jeong, W.-J., Park, J., Kim, T. I., Min, D. S. and Choi, K.-Y., Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. J. Natl. Cancer Inst., 2014, 106, 373–383.
- Perron, N. R. and Brumaghim, J. L., A review of the antioxidant mechanisms of polyphenol compounds related to iron binding. Cell Biochem. Biophys., 2009, 53, 75–100.
- Anand, P. et al., Cancer is a preventable disease that requires major lifestyle changes. Pharm. Res., 2008, 25, 2097–2116.
- Aumiller, V., Balsara, N., Wilhelm, J., Günther, A. and Königshoff, M., WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis. Am. J. Res. Cell Mol. Biol., 2013, 49, 96–104.
- Taraphdar, A. K., Roy, M. and Bhattacharya, R. K., Natural products as inducers of apoptosis: implication for cancer therapy and prevention. Curr. Sci., 2001, 80, 1387–1396.
- Bedi, A. et al., Inhibition of apoptosis during development of colorectal cancer. Cancer Res., 1995, 55, 1811–1816.
- Brunekreef, B., Environmental epidemiology and risk assessment. Toxicol. Lett., 2008, 180, 118–122.
- Gross, A., McDonnell, J. M. and Korsmeyer, S. J., BCL-2 family members and the mitochondria in apoptosis. Genes Dev., 1999, 13, 1899–1911.
- Matsuzawa, S. I. and Reed, J. C., Siah-1, SIP and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses. Mol. Cell, 2001, 7, 915–926.
- Abbas, T. and Dutta, A., p21 in cancer: intricate networks and multiple activities. Nature Rev. Cancer, 2009, 9, 400–414.
- Murata, J., Saiki, I., Matsuno, K., Tokura, S. and Azuma, I., Inhibition of tumor cell arrest in lungs by antimetastatic chitin heparinoid. Jpn. J. Cancer Res., 1990, 81, 506–513.
- Hatsell, S., Rowlands, T., Hiremath, M. and Cowin, P., Betacatenin and Tcfs in mammary development and cancer. J. Mamm. Gland Biol. Neoplasia, 2003, 8, 145–158.
Abstract Views: 349
PDF Views: 153